Hookipa Pharma Inc Reports Results For The Quarter Ended In December: Earnings Summary

Hookipa Pharma

22/03/2024 11:41

* HOOKIPA Pharma Inc  HOOK.OQ  reported a quarterly adjusted
loss
of 22 cents​​ per share for the quarter ended in December, lower
than the same quarter last year, when the company reported EPS
of -17 cents.  The mean expectation of five analysts for the
quarter was for a loss of 19 cents per share. Wall Street
expected results to range from -21 cents to -17 cents per share.
    * Revenue fell 5.4% to $7.41 million from a year ago;
analysts
expected $4.56 million. 
    * HOOKIPA Pharma Inc's reported EPS for the quarter was a
loss
of 22 cents​.
    * The company reported a quarterly loss of $24.82 million.
    * HOOKIPA Pharma Inc shares had fallen by 10.6% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $5.00 

This summary was machine generated from LSEG data March 22 at
11:41 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.19          -0.22          Missed
 Sep. 30 2023      -0.21          -0.17          Beat
 Jun. 30 2023      -0.21          -0.22          Missed
 Mar. 31 2023      -0.23          -0.27          Missed